<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Bausch Health Companies Inc — News on 6ix</title>
    <link>https://6ix.com/company/bausch-health-companies-inc</link>
    <description>Latest news and press releases for Bausch Health Companies Inc on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 29 Apr 2026 20:05:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/bausch-health-companies-inc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835f71378dffbe2df12fe1a.webp</url>
      <title>Bausch Health Companies Inc</title>
      <link>https://6ix.com/company/bausch-health-companies-inc</link>
    </image>
    <item>
      <title>BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-announces-first-quarter-2026-results</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-announces-first-quarter-2026-results</guid>
      <pubDate>Wed, 29 Apr 2026 20:05:00 GMT</pubDate>
      <description>Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (&quot;Bausch Health&quot; or the &quot;Company&quot; or &quot;we&quot; or &quot;our&quot;) today announced its first quarter 2026 financial results and other key updates from the quarter.</description>
    </item>
    <item>
      <title>Bausch Health&apos;s Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through Convenient Online Ordering</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/bausch-healths-dermatology-business-ortho-dermatologics-announces-the-launch-of-biafiner-an-iconic-french-skincare-product-through-convenient-online-ordering</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/bausch-healths-dermatology-business-ortho-dermatologics-announces-the-launch-of-biafiner-an-iconic-french-skincare-product-through-convenient-online-ordering</guid>
      <pubDate>Tue, 14 Apr 2026 12:00:00 GMT</pubDate>
      <description>Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its dermatology business, Ortho Dermatologics, today announced Biafine® Skin Recovery Emulsion is now offered through convenient online ordering in the United States. The well-known French skincare formula is available through select online channels.</description>
    </item>
    <item>
      <title>Bausch Health&apos;s Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine&amp;#xAE;, an Iconic French Skincare Product, Through Convenient Online Ordering</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/bausch-healths-dermatology-business-ortho-dermatologics-announces-the-launch-of-biafineandxae-an-iconic-french-skincare-product-through-convenient-online-ordering</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/bausch-healths-dermatology-business-ortho-dermatologics-announces-the-launch-of-biafineandxae-an-iconic-french-skincare-product-through-convenient-online-ordering</guid>
      <pubDate>Tue, 14 Apr 2026 12:00:00 GMT</pubDate>
      <description>Bausch Health&apos;s Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine&amp;#xAE;,...</description>
    </item>
    <item>
      <title>Bausch Health to Announce First Quarter 2026 Results on April 29, 2026</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-to-announce-first-quarter-2026-results-on-april-29-2026</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-to-announce-first-quarter-2026-results-on-april-29-2026</guid>
      <pubDate>Tue, 31 Mar 2026 11:00:00 GMT</pubDate>
      <description>Bausch Health to Announce First Quarter 2026 Results on April 29, 2026         PR Newswire       ...</description>
    </item>
    <item>
      <title>Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-announces-ortho-dermatologics-2026-aspire-higher-scholarship-program</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-announces-ortho-dermatologics-2026-aspire-higher-scholarship-program</guid>
      <pubDate>Thu, 26 Mar 2026 12:00:00 GMT</pubDate>
      <description>Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program         PR New...</description>
    </item>
    <item>
      <title>Bausch Health&apos;s Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/bausch-healths-aesthetics-business-solta-medical-announces-the-launch-of-clear-brilliantr-touch-laser-in-canada</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/bausch-healths-aesthetics-business-solta-medical-announces-the-launch-of-clear-brilliantr-touch-laser-in-canada</guid>
      <pubDate>Mon, 23 Feb 2026 13:00:00 GMT</pubDate>
      <description>Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and Solta Medical, a global leader in medical aesthetics, today announced the launch of the Clear + Brilliant® Touch laser in Canada. The device was approved by Health Canada on May 20, 2025, marking an important milestone as demand for non‑invasive skin rejuvenation treatments continues to grow across Canada. With this approval, Canadian physicians are able to offer one of the most advanced dual-wave</description>
    </item>
    <item>
      <title>Bausch Health&apos;s Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant&amp;#xAE; Touch Laser in Canada</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/bausch-healths-aesthetics-business-solta-medical-announces-the-launch-of-clear-brilliantandxae-touch-laser-in-canada</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/bausch-healths-aesthetics-business-solta-medical-announces-the-launch-of-clear-brilliantandxae-touch-laser-in-canada</guid>
      <pubDate>Mon, 23 Feb 2026 13:00:00 GMT</pubDate>
      <description>Bausch Health&apos;s Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant&amp;#xA...</description>
    </item>
    <item>
      <title>Bausch Health&apos;s OraPharma Celebrates 25 Years of ARESTIN®  (minocycline HCl) Microspheres</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/bausch-healths-orapharma-celebrates-25-years-of-arestinr-minocycline-hcl-microspheres</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/bausch-healths-orapharma-celebrates-25-years-of-arestinr-minocycline-hcl-microspheres</guid>
      <pubDate>Thu, 19 Feb 2026 13:00:00 GMT</pubDate>
      <description>Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), and its dental products business, OraPharma, today announced the 25th anniversary milestone of ARESTIN® (minocycline HCl) Microspheres, 1 mg, a locally administered antibiotic used as an adjunct to scaling and root planing (SRP) for the reduction of pocket depth in adult patients with periodontitis. ARESTIN is supported by over two decades of clinical experience and remains the only Food and Drug Administration (FDA) approved locally applied anti</description>
    </item>
    <item>
      <title>Bausch Health&apos;s OraPharma Celebrates 25 Years of ARESTIN&amp;#xAE; (minocycline HCl) Microspheres</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/bausch-healths-orapharma-celebrates-25-years-of-arestinandxae-minocycline-hcl-microspheres</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/bausch-healths-orapharma-celebrates-25-years-of-arestinandxae-minocycline-hcl-microspheres</guid>
      <pubDate>Thu, 19 Feb 2026 13:00:00 GMT</pubDate>
      <description>Bausch Health&apos;s OraPharma Celebrates 25 Years of ARESTIN&amp;#xAE; (minocycline HCl) Microspheres    ...</description>
    </item>
    <item>
      <title>BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-announces-fourth-quarter-and-full-year-2025-results</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-announces-fourth-quarter-and-full-year-2025-results</guid>
      <pubDate>Wed, 18 Feb 2026 21:05:00 GMT</pubDate>
      <description>Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (&quot;Bausch Health&quot; the &quot;Company,&quot; &quot;we&quot; or &quot;our&quot;) today announced its fourth quarter and full-year 2025 financial results and other key updates for the quarter.</description>
    </item>
    <item>
      <title>Bausch Health Announces 2026 Gastrointestinal Health Scholars Program</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-announces-2026-gastrointestinal-health-scholars-program</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-announces-2026-gastrointestinal-health-scholars-program</guid>
      <pubDate>Wed, 11 Feb 2026 13:00:00 GMT</pubDate>
      <description>Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals (&quot;Salix&quot;), today announced the opening of the 2026 Salix Gastrointestinal Health Scholars Program application period. The program will award 10 exceptional students living with GI disease a scholarship of up to $10,000 as they work to pursue their higher education goals.</description>
    </item>
    <item>
      <title>Bausch Health Provides Update on RED-C Phase 3 Clinical Trials</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-provides-update-on-red-c-phase-3-clinical-trials</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-provides-update-on-red-c-phase-3-clinical-trials</guid>
      <pubDate>Fri, 23 Jan 2026 12:45:00 GMT</pubDate>
      <description>Bausch Health Provides Update on RED-C Phase 3 Clinical Trials         PR Newswire         LAVAL,...</description>
    </item>
    <item>
      <title>Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-to-announce-fourth-quarter-and-full-year-2025-results-on-february-18-2026</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-to-announce-fourth-quarter-and-full-year-2025-results-on-february-18-2026</guid>
      <pubDate>Wed, 21 Jan 2026 12:00:00 GMT</pubDate>
      <description>Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026         ...</description>
    </item>
    <item>
      <title>Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-to-participate-in-the-44th-annual-jp-morgan-healthcare-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-to-participate-in-the-44th-annual-jp-morgan-healthcare-conference</guid>
      <pubDate>Mon, 05 Jan 2026 12:00:00 GMT</pubDate>
      <description>Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference         PR News...</description>
    </item>
    <item>
      <title>Bausch Health Announces Final Results and Expiration of Exchange Offers</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-announces-final-results-and-expiration-of-exchange-offers</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-announces-final-results-and-expiration-of-exchange-offers</guid>
      <pubDate>Tue, 23 Dec 2025 22:35:00 GMT</pubDate>
      <description>LAVAL, QC /  ACCESS Newswire  / December 23, 2025 /  Bausch Health Companies Inc. (NYSE:BHC)(TSX:...</description>
    </item>
    <item>
      <title>Beauty Devices Markets, Competition and Regional Analysis (2025-2032) Featuring Alma Lasers, Bausch Health, BRAUN, Conair, Cutera, FOREO and More</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/beauty-devices-markets-competition-and-regional-analysis-2025-2032-featuring-alma-lasers-bausch-health-braun-conair-cutera-foreo-and-more</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/beauty-devices-markets-competition-and-regional-analysis-2025-2032-featuring-alma-lasers-bausch-health-braun-conair-cutera-foreo-and-more</guid>
      <pubDate>Tue, 23 Dec 2025 13:51:00 GMT</pubDate>
      <description>The beauty devices market offers growth opportunities through the demand for multifunctional, at-home tech, regional adoption diversity, AI integration, and sustainable design Beauty Devices Market Beauty Devices Market Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The &quot;Beauty Devices Market - Global Forecast 2025-2032&quot; report has been added to ResearchAndMarkets.com&apos;s offering. The beauty devices market is undergoing rapid advancement as consumer preferences, technology, and sustainability reshape</description>
    </item>
    <item>
      <title>Bausch Health Announces Early Exchange Offer Results for Exchange Offers</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-announces-early-exchange-offer-results-for-exchange-offers</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-announces-early-exchange-offer-results-for-exchange-offers</guid>
      <pubDate>Tue, 09 Dec 2025 00:22:00 GMT</pubDate>
      <description>LAVAL, QC /  ACCESS Newswire  / December 8, 2025 /  Bausch Health Companies Inc. (NYSE:BHC)(TSX:B...</description>
    </item>
    <item>
      <title>Bausch Health&apos;s Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/bausch-healths-aesthetics-business-solta-medical-acquires-longtime-distribution-partner-the-shibo-group-to-strengthen-presence-in-china</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/bausch-healths-aesthetics-business-solta-medical-acquires-longtime-distribution-partner-the-shibo-group-to-strengthen-presence-in-china</guid>
      <pubDate>Mon, 01 Dec 2025 12:00:00 GMT</pubDate>
      <description>Transaction boosts Solta Medical&apos;s position to meet rising demand in China&apos;s growing aesthetics m...</description>
    </item>
    <item>
      <title>Bausch Health Announces Launch of Offers to Exchange Certain Existing Senior Secured Notes</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-announces-launch-of-offers-to-exchange-certain-existing-senior-secured-notes</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-announces-launch-of-offers-to-exchange-certain-existing-senior-secured-notes</guid>
      <pubDate>Mon, 24 Nov 2025 12:05:00 GMT</pubDate>
      <description>LAVAL, QC /  ACCESS Newswire  / November 24, 2025 /  Bausch Health Companies Inc. (NYSE:BHC)(TSX:...</description>
    </item>
    <item>
      <title>Bausch Health to Participate in the 8th Annual Evercore Healthcare Conference</title>
      <link>https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-to-participate-in-the-8th-annual-evercore-healthcare-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/bausch-health-companies-inc/news/bausch-health-to-participate-in-the-8th-annual-evercore-healthcare-conference</guid>
      <pubDate>Tue, 18 Nov 2025 12:00:00 GMT</pubDate>
      <description>LAVAL, QC /  ACCESS Newswire  / November 18, 2025 /  Bausch Health Companies Inc. (NYSE:BHC)(TSX:...</description>
    </item>
  </channel>
</rss>